ÂÜÀòÂÒÂ×

Megan DeZago, PhD, is a Senior Scientist at Obsidian Therapeutics, with a previous role as a Process Development Scientist at Prothelia, where significant contributions included improving purification processes for a structural protein replacement therapy. Prior experience includes work at MassBiologics as a Process Development Associate, optimizing cell culture processes for monoclonal antibody production, and participation in a Leadership Development Program at Karl Storz Endovision, where valuable leadership and continuous improvement skills were gained. Education includes a PhD in Biomedical Engineering from Brown University and a Bachelor's Degree in Biomedical Engineering from Worcester Polytechnic Institute.